A new second-generation supraglottic airway device (Ambu® AuraGain•) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial

Background and Aims: The Ambu® AuraGain• is a new single-use supraglottic airway device with gastric channel, designed to facilitate intubation. The study aimed to assess the success rates of proper placement and intubation using Ambu® AuraGain• compared with intubating laryngeal mask airway (ILMA)....

Full description

Bibliographic Details
Main Authors: K Sudheesh, G M Chethana, H Chaithali, S S Nethra, D Devikarani, G Shwetha
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Anaesthesia
Subjects:
Online Access:http://www.ijaweb.org/article.asp?issn=0019-5049;year=2019;volume=63;issue=7;spage=558;epage=564;aulast=Sudheesh
_version_ 1828392493119438848
author K Sudheesh
G M Chethana
H Chaithali
S S Nethra
D Devikarani
G Shwetha
author_facet K Sudheesh
G M Chethana
H Chaithali
S S Nethra
D Devikarani
G Shwetha
author_sort K Sudheesh
collection DOAJ
description Background and Aims: The Ambu® AuraGain• is a new single-use supraglottic airway device with gastric channel, designed to facilitate intubation. The study aimed to assess the success rates of proper placement and intubation using Ambu® AuraGain• compared with intubating laryngeal mask airway (ILMA). Methods: One hundred and twenty patients (18–60 years) were enrolled into this prospective, randomised, comparative study. After inducing general anaesthesia, appropriate size ILMA (group I)/Ambu® AuraGain• (group A) was placed as per the manufacturer's recommendations and correct placement was confirmed. Appropriate size endotracheal tube was passed through the device. The success rate of insertion and intubation, number of attempts, Cormack–Lehane grading before insertion and haemodynamics were recorded. Data were analysed using Mantel–Haenszel Chi-square test, Student's t-test and Fisher's exact test. Results: Demographic and airway parameters were uniformly distributed in both the groups. The success rate for insertion was 100% in both devices. The success rate for intubation was 96.6% (58/60) in group I and 36.6% in group A (P < 0.001). In group I, patients with mean thyromental distance >7.62 ± 0.75 cm had higher successful intubation compared with patients with mean thyromental distance <5.25 ± 0.35 cm (P = 0.014). Cormack–Lehane grading did not correlate with intubation attempts or success rate in group I (P = 0.45), whereas in group A the rate of successful blind intubation with Cormack–Lehane grade 1 was 50% (19/38). Conclusion: Both devices have 100% insertion success, though Ambu® AuraGain• has lower success rate for facilitating intubation compared with ILMA.
first_indexed 2024-12-10T07:20:58Z
format Article
id doaj.art-dff928f6adeb4b6db62684e536410b9c
institution Directory Open Access Journal
issn 0019-5049
0976-2817
language English
last_indexed 2024-12-10T07:20:58Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Anaesthesia
spelling doaj.art-dff928f6adeb4b6db62684e536410b9c2022-12-22T01:57:49ZengWolters Kluwer Medknow PublicationsIndian Journal of Anaesthesia0019-50490976-28172019-01-0163755856410.4103/ija.IJA_269_19A new second-generation supraglottic airway device (Ambu® AuraGain•) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trialK SudheeshG M ChethanaH ChaithaliS S NethraD DevikaraniG ShwethaBackground and Aims: The Ambu® AuraGain• is a new single-use supraglottic airway device with gastric channel, designed to facilitate intubation. The study aimed to assess the success rates of proper placement and intubation using Ambu® AuraGain• compared with intubating laryngeal mask airway (ILMA). Methods: One hundred and twenty patients (18–60 years) were enrolled into this prospective, randomised, comparative study. After inducing general anaesthesia, appropriate size ILMA (group I)/Ambu® AuraGain• (group A) was placed as per the manufacturer's recommendations and correct placement was confirmed. Appropriate size endotracheal tube was passed through the device. The success rate of insertion and intubation, number of attempts, Cormack–Lehane grading before insertion and haemodynamics were recorded. Data were analysed using Mantel–Haenszel Chi-square test, Student's t-test and Fisher's exact test. Results: Demographic and airway parameters were uniformly distributed in both the groups. The success rate for insertion was 100% in both devices. The success rate for intubation was 96.6% (58/60) in group I and 36.6% in group A (P < 0.001). In group I, patients with mean thyromental distance >7.62 ± 0.75 cm had higher successful intubation compared with patients with mean thyromental distance <5.25 ± 0.35 cm (P = 0.014). Cormack–Lehane grading did not correlate with intubation attempts or success rate in group I (P = 0.45), whereas in group A the rate of successful blind intubation with Cormack–Lehane grade 1 was 50% (19/38). Conclusion: Both devices have 100% insertion success, though Ambu® AuraGain• has lower success rate for facilitating intubation compared with ILMA.http://www.ijaweb.org/article.asp?issn=0019-5049;year=2019;volume=63;issue=7;spage=558;epage=564;aulast=SudheeshAmbu® AuraGain•Cormack–Lehane gradeILMAintubationsupraglottic airway device
spellingShingle K Sudheesh
G M Chethana
H Chaithali
S S Nethra
D Devikarani
G Shwetha
A new second-generation supraglottic airway device (Ambu® AuraGain•) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
Indian Journal of Anaesthesia
Ambu® AuraGain•
Cormack–Lehane grade
ILMA
intubation
supraglottic airway device
title A new second-generation supraglottic airway device (Ambu® AuraGain•) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title_full A new second-generation supraglottic airway device (Ambu® AuraGain•) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title_fullStr A new second-generation supraglottic airway device (Ambu® AuraGain•) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title_full_unstemmed A new second-generation supraglottic airway device (Ambu® AuraGain•) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title_short A new second-generation supraglottic airway device (Ambu® AuraGain•) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial
title_sort new second generation supraglottic airway device ambu r auragain• versus intubating laryngeal mask airway as conduits for blind intubation a prospective randomised trial
topic Ambu® AuraGain•
Cormack–Lehane grade
ILMA
intubation
supraglottic airway device
url http://www.ijaweb.org/article.asp?issn=0019-5049;year=2019;volume=63;issue=7;spage=558;epage=564;aulast=Sudheesh
work_keys_str_mv AT ksudheesh anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT gmchethana anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT hchaithali anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT ssnethra anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT ddevikarani anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT gshwetha anewsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT ksudheesh newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT gmchethana newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT hchaithali newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT ssnethra newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT ddevikarani newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial
AT gshwetha newsecondgenerationsupraglotticairwaydeviceambuauragainversusintubatinglaryngealmaskairwayasconduitsforblindintubationaprospectiverandomisedtrial